IP Library Granted Patent US 7,531,341
Granted Patent B1
US 7,531,341 · App. 11/451,999 · Granted May 12, 2009

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,531,341
App. No.
11/451,999
Granted
May 12, 2009
Kind
B1
Abstract

The present invention is directed to phenylalanine ammonia lyase (PAL) produced by prokaryotes, wherein such prokaryotic PAL wherein the PAL variant has a greater phenylalanine-converting activity as compared to a wild-type PAL. The invention thus provides compositions of bacterial PAL and biologically active fragments, mutants, variants and analogs thereof, as well as methods for the production, purification, and use of such compositions for therapeutic and industrial purposes.

Claims (6)

1. A wild-type Anabaena variabilis phenylalanine ammonia lyase comprising a polyethylene glycol.

2. The phenylalanine ammonia lyase of claim 1 having a phenylalanine ammonia lyase:polyethylene glycol ratio of 1:3.

3. A pharmaceutical composition comprising the phenylalanine ammonia lyase of claim 1 and a pharmaceutically acceptable carrier.

4. A wild-type Nostoc punctiforme phenylalanine ammonia lyase comprising a polyethylene glycol.

5. The phenylalanine ammonia lyase of claim 4 having a phenylalanine ammonia lyase:polyethylene glycol ratio of 1:3.

6. A pharmaceutical composition comprising the phenylalanine ammonia lyase of claim 4 and a pharmaceutically acceptable carrier.

Assignments (2)
SECURITY INTEREST Recorded Apr 27, 2026
From: BIOMARIN PHARMACEUTICAL INC.; AMICUS THERAPEUTICS, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 075493/0968 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2006
From: VELLARD, MICHEL CLAUDE; FITZPATRICK, PAUL ANDREW; KAKKIS, EMIL D.
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 017994/0520 →